Skip to main content
. 2022 Oct 1;10(10):2453. doi: 10.3390/biomedicines10102453

Table 1.

Mitochondria-targeted therapies for UC.

Therapies Strategies Targets References
DCA inhibit PDK and activate PDH mitochondrial TCA [76]
vitamin K2 promote the glycolysis mitochondrial TCA [78]
AS-ODNs improve drug sensitivity
induce apoptosis
BCL-2, NRB1 [84,85]
siRNA improve drug sensitivity
induce apoptosis
BCL-2, NRB1 [66]
metformin induce apoptosis mitochondria [77]
silibinin induce apoptosis mitochondria [86]
baicalein induce apoptosis mitochondria [100]
resveratrol induce apoptosis mitochondria [104,105]
CXC195 induce apoptosis TMP analog [79]
TRAIL induce apoptosis mitochondria [106]
UVA damage mitochondria mitochondria [110]

AS-ODNs, antisense oligodeoxynucleotides; siRNA, small interfering RNA; TMP, tetramethylpyrazine; TRAIL, tumor necrosis factor (TNF)-related apoptosis-inducing ligand; DCA, dichloroacetate; PDK, pyruvate dehydrogenase kinase; PDH, pyruvate dehydrogenase; UVA, ultraviolet A.